Salomaa Sisko, Jourdain Jean-René, Kreuzer Michaela, Jung Thomas, Repussard Jacques
a University of Eastern Finland, Kuopio and STUK, Radiation and Nuclear Safety Authority , Helsinki , Finland.
b IRSN, Institute for Radiological Protection and Nuclear Safety , Fontenay-aux-Roses , France.
Int J Radiat Biol. 2017 Oct;93(10):1035-1039. doi: 10.1080/09553002.2017.1281463. Epub 2017 Feb 8.
This paper provides an update and summary on the organization of European research in the field of low dose risk and radiation protection. To address declining resources and competence in radiation protection and related research across European countries, a High Level and Expert Group (HLEG) was established in 2007. The HLEG identified key policy and scientific questions to be addressed through a strategic research agenda for low dose radiation risk. This initiated the establishment of a European Research Platform, called MELODI (Multidisciplinary European Low Dose Research Initiative). Dr Bill Morgan closely followed the European low dose programme and chaired the international Advisory Boards of DoReMi Network of Excellence and the MELODI platform.
The MELODI research platform is dedicated to low dose ionizing radiation risk. In 2010, MELODI was founded as a registered association with 15 members. As of September 2016, the association´s membership increased to 46. A major activity of MELODI is the establishment and updating of a long-term Strategic Research Agenda (SRA) for research on low dose risk in Europe. The SRA is intended to guide the priorities for national and European research programmes and the preparation of competitive calls at the European level. A key priority for radiation protection research is to improve health risk estimates for exposures corresponding to the dose limits for occupational exposures and to reference levels for the exposure of the population in emergency situations.
本文提供了欧洲低剂量风险与辐射防护领域研究组织的最新情况和总结。为应对欧洲各国辐射防护及相关研究资源和能力不断下降的问题，2007年成立了一个高级别专家组（HLEG）。该专家组确定了需通过低剂量辐射风险战略研究议程加以解决的关键政策和科学问题。这促成了一个名为MELODI（欧洲低剂量多学科研究倡议）的欧洲研究平台的建立。比尔·摩根博士密切关注欧洲低剂量计划，并担任卓越DoReMi网络和MELODI平台的国际咨询委员会主席。
MELODI研究平台致力于低剂量电离辐射风险研究。2010年，MELODI作为一个拥有15名成员的注册协会成立。截至2016年9月，该协会成员增加到46名。MELODI的一项主要活动是制定和更新欧洲低剂量风险研究的长期战略研究议程（SRA）。该SRA旨在指导国家和欧洲研究计划的优先事项以及欧洲层面竞争性项目申请的准备工作。辐射防护研究的一个关键优先事项是改进与职业照射剂量限值及紧急情况下公众照射参考水平相对应的照射健康风险估计。
